Image 1
Finasteride Tablet, Film Coated
Product Images NDC 0093-7355
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 0093-7355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
Image 4
This looks like a table summarizing the percent change from a baseline measurement over four years for two groups, one taking a placebo and the other taking Finasteride. However, without additional context or a description of what is being measured, it's hard to say more than that.*
Image 5
The text describes a graph labeled as "Figure 5" which shows the cumulative incidence of a 4-point rise in AUA symptom score by treatment group. The graph shows percentages on the y-axis and years from randomization on the x-axis. The treatment groups are not described in the given text.*
Image 6
Usual adult dosage for an unidentified medication is 5mg taken once a day. The medication should be stored within the temperature range of 20°C to 25°C (68°F to 77°F). The users should keep the medication out of the reach of children. The given text may belong to a medication label or prescription. No further information is available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
